These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 24054864

  • 1. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M, Gandaglia G, Trinh QD, Hansen J, Becker A, Abdollah F, Tian Z, Lughezzani G, Roghmann F, Briganti A, Montorsi F, Karakiewicz PI, Sun M.
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [Abstract] [Full Text] [Related]

  • 2. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [Abstract] [Full Text] [Related]

  • 3. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [Abstract] [Full Text] [Related]

  • 4. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.
    Sun M, Becker A, Tian Z, Roghmann F, Abdollah F, Larouche A, Karakiewicz PI, Trinh QD.
    Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066
    [Abstract] [Full Text] [Related]

  • 5. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
    Sun M, Bianchi M, Trinh QD, Hansen J, Abdollah F, Hanna N, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.
    BJU Int; 2013 Jan; 111(1):67-73. PubMed ID: 22612472
    [Abstract] [Full Text] [Related]

  • 6. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
    Marchioni M, Preisser F, Bandini M, Nazzani S, Tian Z, Kapoor A, Cindolo L, Abdollah F, Tilki D, Briganti A, Montorsi F, Shariat SF, Schips L, Karakiewicz PI.
    Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
    [Abstract] [Full Text] [Related]

  • 8. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
    Daugherty M, Bratslavsky G.
    Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
    [Abstract] [Full Text] [Related]

  • 9. Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
    Sun M, Bianchi M, Hansen J, Abdollah F, Trinh QD, Lughezzani G, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.
    Int J Urol; 2013 Apr; 20(4):372-80. PubMed ID: 23039208
    [Abstract] [Full Text] [Related]

  • 10. A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
    Sun M, Abdollah F, Bianchi M, Trinh QD, Jeldres C, Tian Z, Shariat SF, Widmer H, Zorn K, Menon M, Montorsi F, Perrotte P, Karakiewicz PI.
    Eur Urol; 2011 Dec; 60(6):1152-9. PubMed ID: 21868147
    [Abstract] [Full Text] [Related]

  • 11. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L, Patard JJ, Capitanio U, Crepel M, de La Taille A, Tostain J, Ficarra V, Bernhard JC, Ferrière JM, Pfister C, Villers A, Montorsi F, Karakiewicz PI.
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [Abstract] [Full Text] [Related]

  • 12. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
    Bianchi M, Becker A, Hansen J, Trinh QD, Tian Z, Abdollah F, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI, Sun M.
    BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
    [Abstract] [Full Text] [Related]

  • 13. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [Abstract] [Full Text] [Related]

  • 14. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI.
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [Abstract] [Full Text] [Related]

  • 15. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, Saad F, Patard JJ, Montorsi F, Karakiewicz PI.
    Cancer; 2009 Apr 01; 115(7):1465-71. PubMed ID: 19195042
    [Abstract] [Full Text] [Related]

  • 16. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
    Capitanio U, Perrotte P, Zini L, Jeldres C, Shariat SF, Isbarn H, Arjane P, Peloquin F, Pharand D, Montorsi F, Karakiewicz PI.
    BJU Int; 2009 Sep 01; 104(6):795-9. PubMed ID: 19389018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
    May M, Cindolo L, Zigeuner R, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Wolff I, Feciche B, Fenske F, Pichler M, Schips L, Figenshau RS, Madison K, Sánchez-Chapado M, Santiago Martin Mdel C, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Sountoulides P, Brookman-May S, Members of CORONA project, Young Academic Urologists Renal Cancer Group.
    Urol Oncol; 2014 Nov 01; 32(8):1252-8. PubMed ID: 25129141
    [Abstract] [Full Text] [Related]

  • 19. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.
    Eur Urol; 2013 Oct 01; 64(4):600-6. PubMed ID: 23280319
    [Abstract] [Full Text] [Related]

  • 20. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B, Hanley J, Lai J, Vourganti S, Kim SP, Setodji CM, Dick AW, Chow WH, Saigal C, Urologic Diseases in America Project.
    Cancer; 2013 Aug 15; 119(16):2981-9. PubMed ID: 23674264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.